3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
14
Myelodysplastic Syndromes
6
Advanced Solid Tumors
5
Advanced Solid Tumour
4
Small Cell Lung Carcinoma
3
Recurrence
3
Myeloproliferative Disorders
3
Leukemia, Myelomonocytic, Chronic
3
Carcinoma, Non-Small-Cell Lung
3
Neoplasm Metastasis
2
Multiple Myeloma
2
Esophageal Squamous Cell Carcinoma
2
Advanced Solid Tumor
2
Unresectable Locally Recurrent Breast Cancer
1
Squamous Cell Carcinoma of Head and Neck
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Non-small Lung Cancer
1
Non-Muscle Invasive Bladder Neoplasms
1
Neuroma
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Multiple Sclerosis
1
Metastatic Solid Tumors
1
Lung Neoplasms
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Monocytic, Acute
1
Leukemia, Biphenotypic, Acute
1
Idiopathic Pulmonary Fibrosis
1
Interventions
AZD 6244
6
trametinib
2
talimogene laherparepvec
1
omipalisib
1
mirdametinib
1
lorlatinib
1
encorafenib
1
dabrafenib
1
binimetinib
1
Specimen Handling
1
Sirolimus
1
Lasers, Solid-State
1
Lasers
1
Curcumin
1
Cetuximab
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neurofibromatosis 1
×
Injections
×
30 days
×
Clear all
No trials found.